BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9603234)

  • 1. Molecular biological aspects of acquired bullous diseases.
    Dabelsteen E
    Crit Rev Oral Biol Med; 1998; 9(2):162-78. PubMed ID: 9603234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucocutaneous features of autoimmune blistering diseases.
    Weinberg MA; Insler MS; Campen RB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Nov; 84(5):517-34. PubMed ID: 9394385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bullous autoimmune diseases of the oral mucosa].
    Vaillant L
    Rev Stomatol Chir Maxillofac; 1999 Oct; 100(5):230-9. PubMed ID: 10604215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
    Jenkins RE; Rodenas J; Bhogal BS; Black MM
    Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New immunomodulating drugs in autoimmune blistering diseases.
    Korman NJ
    Dermatol Clin; 2001 Oct; 19(4):637-48, viii. PubMed ID: 11705351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathology and molecular diagnosis of autoimmune bullous diseases.
    Mihai S; Sitaru C
    J Cell Mol Med; 2007; 11(3):462-81. PubMed ID: 17521373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of autoimmune bullous dermatosis with features of pemphigus vulgaris and bullous pemphigoid.
    Kore-eda S; Horiguchi Y; Ohtoshi E; Tanaka T; Fujii K; Okamoto H; Ikai K; Imamura S
    Am J Dermatopathol; 1995 Oct; 17(5):511-6. PubMed ID: 8599459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens: differences in organ and species specificities and localization in chemically-separated human skin of three basement membrane antigens.
    Fine JD
    Coll Relat Res; 1985 Sep; 5(4):369-77. PubMed ID: 3902344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
    Peng TK; Nisengard RJ; Levine MJ; Beutner EH
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?
    Shipman AR; Cooper S; Wojnarowska F
    Clin Exp Dermatol; 2011 Apr; 36(3):267-9. PubMed ID: 20569254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Salt-split' test on normal, non-sun-exposed skin of patients with autoimmune subepidermal bullous diseases.
    Pohla-Gubo G; Becher E; Romani N; Fritsch P; Hintner H
    Dermatology; 1994; 189 Suppl 1():123. PubMed ID: 8049551
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiopathology of autoimmune bullous dermatoses of the basement membrane].
    Salmon-Ehr V; Bernard P
    Ann Dermatol Venereol; 1998 Nov; 125(11):817-23. PubMed ID: 9856264
    [No Abstract]   [Full Text] [Related]  

  • 13. Research Techniques Made Simple: Mouse Models of Autoimmune Blistering Diseases.
    Pollmann R; Eming R
    J Invest Dermatol; 2017 Jan; 137(1):e1-e6. PubMed ID: 28010761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin.
    Gao SQ; Bystryn JC
    J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune bullous skin disorders].
    Hertl M; Niedermeier A; Borradori L
    Ther Umsch; 2010 Sep; 67(9):465-82. PubMed ID: 20806175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
    Fine JD
    J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent progress in studies on autoantigens for various autoimmune blistering skin diseases.
    Hashimoto T
    Keio J Med; 1995 Dec; 44(4):115-23. PubMed ID: 8587223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.